Neogen Corporation

As of May 31, 2026, Neogen Corp carries a market capitalization of 1.68B, placing it among publicly traded companies globally. Its enterprise value stands at 2.20B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Neogen Corp's next confirmed earnings release is scheduled for January 14, 2027.

As of May 31, 2026, Neogen Corp has 217.70M shares outstanding.

These figures are as of May 31, 2026. The price-to-sales ratio is 2.25, and the price-to-book ratio stands at 0.94.

As of May 31, 2026, Neogen Corp trades at an EV/EBITDA multiple of 25.62 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.95 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 2.20B versus a market cap of 1.68B, with the gap driven by net debt and cash on the balance sheet.

As of May 31, 2026, Neogen Corp maintains a current ratio of 3.82, meaning it holds 3.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 37.92, indicating elevated leverage, while an interest coverage ratio of 1.70 demonstrates limited ability to service its debt obligations.

Over the twelve months ended May 31, 2026, Neogen Corp posted a negative return on equity (ROE) of -0.38, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -0.23, reflecting losses generated across the asset base. The company generates approximately 258,387.94 in revenue per employee across its workforce of 2,889.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.76 indicates how many times Neogen Corp sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended May 31, 2026, Neogen Corp recorded an income tax benefit of -917,846.00 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -7.68M and -6.76M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Neogen Corp's stock has gained approximately 102.48% over the past 52 weeks. The 50-day moving average sits at 10.65, while the 200-day moving average is 8.94.

Over the twelve months ended May 31, 2026, Neogen Corp generated 746.61M in revenue and converted that into -6.76M in net income, yielding earnings per share of -0.03. EBITDA reached 85.98M, while operating income came in at -18.59M.

As of May 31, 2026, Neogen Corp holds 159.12M in cash and equivalents against 680.84M in total debt, resulting in a net debt position of 521.71M. Total book value stands at 1.80B, with working capital of 382.92M providing operational flexibility.

Neogen Corp produced 71.37M in operating cash flow over the twelve months ended May 31, 2026. After subtracting -44.01M in capital expenditures, free cash flow totaled 27.36M - equivalent to 0.13 per share.

Over the twelve months ended May 31, 2026, Neogen Corp posted a gross margin of 46.93, reflecting its pricing power and cost economics. The operating margin of -2.49 and net profit margin of -0.91 provide insight into operational efficiency.

These figures cover the twelve months ended May 31, 2026. Free cash flow yield stands at 1.63, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 5.07, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Neogen Corp shareholders.

Neogen Corp's most recent stock split took place on June 7, 2021 with a 1:2 split ratio.

As of May 31, 2026, Neogen Corp has an Altman Z-Score of 1.52, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.